1. Home
  2. VABK vs KROS Comparison

VABK vs KROS Comparison

Compare VABK & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$50.44

Market Cap

265.4M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.31

Market Cap

222.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
KROS
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.4M
222.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
VABK
KROS
Price
$50.44
$11.31
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $19.83
AVG Volume (30 Days)
8.0K
★ 161.7K
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 2.88%
N/A
EPS Growth
12.70
★ 146.00
EPS
★ 2.62
N/A
Revenue
N/A
★ $243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.35
$9.69
52 Week High
$52.69
$22.55

Technical Indicators

Market Signals
Indicator
VABK
KROS
Relative Strength Index (RSI) 57.90 51.22
Support Level $46.42 $10.82
Resistance Level N/A $11.86
Average True Range (ATR) 1.33 0.54
MACD -0.00 -0.03
Stochastic Oscillator 54.71 43.25

Price Performance

Historical Comparison
VABK
KROS

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: